Research Education Core
Research Education Core
批准号:
10693359
负责人:
Shailesh Singh
金额:
$22.22万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
未结题
起止时间:
2005-09-30 至 2026-08-31
关键词:
African American populationAgeAlabamaAptitudeBiomedical ResearchCancer Research ProjectCareer MobilityCaringClinical ResearchColorectal CancerCommunicationCommunitiesComprehensive Cancer CenterDiagnosisDiverse WorkforceEducationEducational ActivitiesEducational CurriculumEvaluationExposure toFacultyFeedbackFellowshipFundingFutureGoalsGrantHealthHealth Disparities ResearchHealthcareHigh School StudentImmersionIncidenceInformaticsInfrastructureInstitutionInterviewJointsLaboratoriesLatinxLearningLinkMalignant NeoplasmsMalignant neoplasm of lungMalignant neoplasm of prostateMedicalMedical StudentsMentorsMethodsMinority GroupsMorehouse School of MedicineMovementOutcomePatientsPoliciesPostdoctoral FellowProductivityPublicationsResearchResearch PersonnelResearch Project GrantsScienceScientistStructureStudentsTrainingUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesanticancer researchcancer educationcancer health disparitycancer therapycancer typecareercareer developmentcollegeeducation researchethnic disparityethnic diversityethnic minorityexperiencegraduate schoolgraduate studenthands on researchhigh schoolimprovedinterestmedical schoolsmembermenmortalityoutreachprogramsracial disparityracial diversityracial minorityrecruitresponserural arearural settingskillssocial mediastatisticssummer programundergraduate studentunderserved minorityurban areaurban setting
中文摘要
课程摘要:研究型教育核心
(这一核心对于所有三家合作机构都是相同的)
莫尔豪斯医学院(MSM)/塔斯基吉大学(TU)/华盛顿大学之间的合作
阿拉巴马州伯明翰奥尼尔综合癌症中心(MSM/TU/UAB OCCC)展示了一种独特的
有机会在我们成功教育的基础上,为未来的癌症研究科学家提供
通过我们的渠道,重点是代表性不足的少数族裔。在此次U54更新中
应用程序,我们建议无缝整合我们的癌症教育计划,重点是“硬”
(通过以前的U54资助开发的结构化课程/培训)和“软”技能(例如,职业
发展路线图、采访技能),以促进通过我们的渠道进入癌症
研究连续体,目标是拥有一支多元化的癌症研究队伍。这将会实现的
通过以下具体目标:目标1.开展和实施综合癌症研究教育
计划将高中、本科生和研究生/医学生与博士后研究员、医学
住院医生、早期调查人员(ESIS)和高级研究人员/导师,特别关注
在科学界代表不足的种族/少数民族。将利用四个综合方案:(A)赠款
通过创建激动人心的科学学习实验室(培养细胞)创造健康的研究机会
面向高中生;(B)面向本科生的癌症研究沉浸式学生计划(CRISP)
(C)为研究生和医学生设立的癌症研究暑期教育方案;
以及(D)针对住院医师、博士后的健康差距研究教育方案
兄弟们,还有伊希斯。目标2.将各级癌症研究学者与外联核心联系起来,分享他们的
与社区成员一起研究结果,获取社区对相关主题的反馈,以供未来研究
(例如,癌症信息咖啡馆S),并为非专业受众开发出版物和交流(例如,博客或帖子
在社交媒体、YouTube视频、政策简报上)。目标3.实施混合方法、三角评估
拟议中的研究教育活动正在筹备之中。这些努力将增加招聘和
保留科学中代表性不足的少数群体,特别是在癌症研究中,这与
在美国国立卫生研究院的多样性兴趣声明中表达的目标。
英文摘要
PROGRAM SUMMARY: RESEARCH EDUCATION CORE
(This Core is identical for all three Partnering Institutions)
The Partnership between Morehouse School of Medicine (MSM)/Tuskegee University (TU)/University of
Alabama at Birmingham O’Neal Comprehensive Cancer Center (MSM/TU/UAB OCCC) presents a distinctive
opportunity to build on our successful accomplishments in education of future cancer research scientists moving
through our pipeline, with an emphasis on underrepresented racial/ethnic minorities. In this U54 renewal
application, we propose a seamless integration of our cancer education programs by focusing on “hard”
(structured courses/training developed through previous U54 funding) and “soft” skills (e.g., career
development roadmap, interviewing skills) needed to facilitate movement through our pipeline into the cancer
research continuum, with the goal of having a diverse workforce in cancer research. This will be accomplished
through the following specific aims: Aim 1. To develop and implement integrated cancer research education
programs to link high school, undergraduate, and graduate/medical students with postdoctoral fellows, medical
residents, and Early Stage Investigators (ESIs), and senior-level researchers/mentors with a particular focus on
underrepresented racial/ethnic minorities in science. Four integrated programs will be utilized: (a) the Granting
Research Opportunities in Wellness by Creating Exciting Learning Laboratories in Science (GROW CELLS)
for high school students; (b) the Cancer Research Immersion Student Program (CRISP) for undergraduate
students; (c) the Summer Cancer Research Education Program (SCREP) for graduate and medical students;
and (d) the Health Disparities Research Education Program (HDREP) for medical residents, postdoctoral
fellows, and ESIs. Aim 2. To link all levels of cancer research scholars with the Outreach Core to share their
research findings with community members, obtain community feedback on relevant topics for future research
(e.g., Cancer Info Cafés), and develop publications and communications for lay audiences (e.g., blogs or posts
on social media, YouTube videos, policy briefs). Aim 3. To implement a mixed-method, triangulated evaluation
of the proposed research education activities across the pipeline. These efforts will increase the recruitment and
retention of underrepresented minorities in science, specifically in cancer research, that are congruent with the
goals expressed in the NIH’s Interest in Diversity Statement.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anti-CCL25 mAb to treat castration resistant prostate cancer
-
批准号:9264953
-
项目类别:
-
资助金额:$35.0万
-
财政年份:2017
-
负责人:Shailesh Singh
-
依托单位:
Anti-CXCL13 mAb to mitigate prostate cancer health disparities
-
批准号:8998175
-
项目类别:
-
资助金额:$31.53万
-
财政年份:2015
-
负责人:Shailesh Singh
-
依托单位:
Role of chemokine receptor in disparities associated with prostate cancer progres
-
批准号:8918551
-
项目类别:
-
资助金额:$18.39万
-
财政年份:2013
-
负责人:Shailesh Singh
-
依托单位:
Role of chemokine receptor in disparities associated with prostate cancer progres
-
批准号:9340094
-
项目类别:
-
资助金额:$9.58万
-
财政年份:2013
-
负责人:Shailesh Singh
-
依托单位:
Role of chemokine receptor in disparities associated with prostate cancer progres
-
批准号:9137633
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2013
-
负责人:Shailesh Singh
-
依托单位:
Role of chemokine receptor in disparities associated with prostate cancer progres
-
批准号:8585726
-
项目类别:
-
资助金额:$21.23万
-
财政年份:2013
-
负责人:Shailesh Singh
-
依托单位:
Role of chemokine receptor in disparities associated with prostate cancer progres
-
批准号:8728793
-
项目类别:
-
资助金额:$20.59万
-
财政年份:2013
-
负责人:Shailesh Singh
-
依托单位:
Role of CCL25-CCR9 in Prostate Cancer
-
批准号:8638910
-
项目类别:
-
资助金额:$35.38万
-
财政年份:2013
-
负责人:Shailesh Singh
-
依托单位:
Role of CCL25-CCR9 in Prostate Cancer
-
批准号:8414694
-
项目类别:
-
资助金额:$35.38万
-
财政年份:2013
-
负责人:Shailesh Singh
-
依托单位:
Prostate Cancer Chemoprevention using a Natural Agent
-
批准号:8445062
-
项目类别:
-
资助金额:$18.47万
-
财政年份:2013
-
负责人:Shailesh Singh
-
依托单位:
Research Education Core
-
批准号:10007640
-
项目类别:
-
资助金额:$14.75万
-
财政年份:2005
-
负责人:Shailesh Singh
-
依托单位:
Research Education Core
-
批准号:10327915
-
项目类别:
-
资助金额:$22.67万
-
财政年份:2005
-
负责人:Shailesh Singh
-
依托单位:
Research Education Core
-
批准号:9368967
-
项目类别:
-
资助金额:$27.48万
-
财政年份:--
-
负责人:Shailesh Singh
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: